Introduction
The transcription factor NF-kB was ®rst identi®ed as a nuclear factor that bound to an enhancer element in the k light chain gene (Sen and Baltimore, 1986) . NFkB is a pleiotropic activator that plays an important role in diverse cellular responses including in¯amma-tion, apoptosis and transformation (Baeuerle and Henkel, 1994; Foo and Nolan, 1999; Sharma and Narayanan, 1996) . NF-kB is comprised of a family of related proteins belong to the Rel family that can heterodimerize or homodimerize to facilitate their binding to the NF-kB site, resulting in activation of gene expression (Baeuerle and Baltimore, 1996) . Conserved among the family of NF-kB proteins is the Rel homology domain which enables NF-kB to bind to the NFkB elements, formation of homodimers or heterodimers with other members of the family, as well as interactions with members of the IkB family of ankyrin-containing proteins (Foo and Nolan, 1999; Piette et al., 1997) . These structurally related proteins include IkBa, IkBb, and IkBe are inhibitors of NF-kB function. NFkB is normally sequestered in the cytoplasm where it is bound by IkBs. A variety of stimuli including treatment with TNF-a, IL-1, lipopolysaccharide and phorbol esters result in activation of NF-kB (Siebenlist et al., 1994) . In addition, oxidative or physical stress (UV and ionizing radiation) can also result in NF-kB activation. Recently, it was found that certain growth factors such as insulin-like growth factor I (IGF-I) can also activate NF-kB (Heck et al., 1999) .
These stimuli modulate signal transduction pathways leading to activation of upstream kinases including NF-kB-induced kinase (NIK) and MEKK1 which activate IkB kinases (IKKs) (Maniatis, 1997) . The signal transduction cascade leading to activation of NF-kB involves phosphorylation and activation of IKKa and IKKb. Activated IKKs phosphorylate IkB, leading to its subsequent ubiquitination and degradation by the proteasome and resulting in the nuclear translocation of NF-kB. Hence, IkBs play crucial roles in regulating activation of NF-kB.
Although NF-kB was initially identi®ed as a transcription factor involved in immune reponses and cytokine production, increasing evidence support its role in regulating cell growth, oncogenesis and apoptosis. As reviewed by Mayo and Baldwin (2000) , the link between NF-kB and cancer stems from the fact that this transcription factor regulates the induction of gene products that control proliferative responses and apoptotic cascades. The ®rst evidence linking Rel to tumorigenesis comes from the identi®cation of its oncogenic counterpart, v-Rel, from an acutely transforming and replication-defective avian reticuloendotheliosis virus which induced fatal tumors within 10 days (Wilhemsen et al., 1984) . Antisense inhibition of the p65 subunit of NF-kappa B has been shown to block tumorigenicity and cause tumor regression (Higgins et al., 1993) . Recently, inhibition of NF-kB function by expression of a dominant-negative mutant form of IkBa in human head and neck squamous cell carcinoma has also been shown to inhibit survival, proin¯ammatory cytokine expression and tumor growth in vivo (Duey et al., 1999) . Expression of mutant IkBa is cytotoxic to squamous lung carcinoma cells and sensitizes them to TNFa-mediated cell death (Batra et al., 1999) . Interestingly, the cytotoxic eects of IkBa appeared to be speci®c for cancer cells because adenoviral-mediated gene transfer of dominant-negative IkBa mutant resulted in decrease in tumor cell viability and proliferation of sarcoma cell lines without having deleterious eect on normal cell lines (Feig et al., 1999) . Recently, expression of a dominant-negative IkBa has been shown to inhibit subcutaneous tumor growth and lung metastasis of human melanoma cells in nude mice (Huang et al., 2000) .
In this study, we have investigated the eects of expression of wild-type IkBb in the transformation of human lung carcinoma cells. We have recently reported that expression of dominant-negative IGF-I receptor in A549 lung carcinoma cells suppressed anchorageindependent growth and tumorigenicity in nude mice and sensitized cells to apoptosis-inducing agents (Jiang et al., 1999) . Like that of dominant-negative IGF-I receptor, expression of IkBb in A549 cells also inhibited anchorage-independent growth and sensitized cells to apoptosis induced by proteasome inhibitors. Interestingly, EGF but not IGF-I could restore the colony forming ability of IkBb-expressing cells. Expression of IkBb also inhibited growth of A549 cells in reduced serum but has no eect on in vivo growth subcutaneously in nude mice. However, metastatic growth of A549 cells in the lungs after intravenous injection is inhibited. These results suggest that NF-kB is important for anchorage-independent growth and metastasis of lung carcinoma cells.
Results

Inhibition of anchorage-independent growth of K-ras transformed NIH3T3 and lung carcinoma cells by IkBb
It has been shown that activation of the NF-kB pathway is important for transformation by oncogenic ras (Finco et al., 1997; Mayo et al., 1997; Arsura et al., 2000) . To ascertain the inhibitory role of IkBb in cellular transformation by K-ras, K-ras-transformed NIH3T3 cells were transfected with pBEF/neo (vector) or pBEF/IkBb-HA (IkBb tagged at the carboxyl-terminus with an HA epitope) and anchorage-independent growth was assayed by plating cells in 0.4% agar 24 h after transfection. As shown in Figure 1a , transient transfection of IkBb-HA inhibited colony formation of K-rastransformed NIH3T3 cells. In contrast, vector-transfected K-ras-transformed NIH3T3 cells formed numerous large sized colonies whereas IkBb-HA-transfected cells formed fewer number and smaller sized colonies.
Since human lung carcinoma cells often harbor activating mutations in the protooncogene K-ras, we examined the eects of expression of IkBb on transformation of the H441 and A549 human lung adenocarcinoma cells which harbored mutations at codon 12 of the K-ras gene (Mitsudomi et al., 1991) . Similar to K-ras-transformed NIH3T3 cells, transfection of IkBb-HA similarly inhibited anchorage-independent growth of H441 cells (Figure 1b) . To con®rm the inhibitory eect of IkBb in another lung adenocarcinoma cancer cell line with oncogenic K-ras mutation, anchorage-independent growth was assayed in A549 cells transfected with increasing concentrations of the IkBb-HA plasmid. Inhibition of colony formation of A549 cells by IkBb was dose-dependent and was observed with transfections of 4150 ng DNA (Figure 1c, upper panel (clones 4, 5, 8, 9, 10 and 12) were assayed for anchorage-independent growth (Figure 2a, upper panel) . Vector-transfected A549 cells formed numerous, large colonies while the colony forming ability of all six IkBb-expressing clones was dramatically reduced (Figure 2a , lower panel). Thus, both transient and stable expression of IkBb protein suppressed anchorage-independent growth of A549 cells. These data suggest that NF-kB plays an important role in anchorage-independent growth of lung cancer cells and are consistent with the ®ndings of Higgins et al. (1993) that antisense oligonucleotides to the p65 subunit of NF-kB inhibited colony formation in soft agar.
We have previously shown that expression of dominant-negative IGF-I receptor (IGF-IR) in A549 cells inhibited colony formation in soft agar (Jiang et al., 1999) . Recently, the c-Jun N-terminal kinase 2 (JNK2) has been shown to be required for EGFstimulated anchorage-independent growth of A549 cells (Bost et al., 1999) . To ascertain the role of IGF-I and EGF, the six IkBb-expressing clones were pooled (IkBb-HA pool) and anchorage-independent growth was examined. As shown in Figure 2b , the pooled vector-transfected A549 clones (vector pool) formed numerous large colonies in soft agar in 10% FBS in the absence (7) or presence (+) of IGF-I. On the other hand, the pooled IkBb-HA clones, similar to the individual IkBb-HA-expressing clones (Figure 2a ), formed fewer and smaller colonies in 10% FBS in the absence (7) or presence (+) of IGF-I (Figure 2b , IGF-I, lower panel). When cultured in reduced serum (5 and 2.5% FBS) in the absence of IGF-I (7), the ability to form colonies in soft agar of vector control cells was reduced as compared to that of 10% FBS (7). Addition of IGF-I (+) enhanced colony formation of vector control cells in reduced serum (both 5 and 2.5% FBS). In contrast, addition of IGF-I (+) failed to stimulate colony formation of IkBb-expressing cells cultured at 10, 5 or 2.5% FBS (Figure 2b , IGF-I, lower panel). Interestingly, addition of EGF (+) enhanced colony formation of both vector control and IkBb-expressing cells grown in reduced serum (5 and 2.5% FBS) (Figure 2b , EGF, lower panel). Hence, both IGF-I and EGF stimulated colony formation of vector control cells in both 2.5 and 5% FBS but only EGF could stimulate anchorage-independent growth of IkBb-expressing cells, suggesting that NF-kB may be required for IGF-stimulated colony formation.
Inhibition of NF-kB activation by IkBb expression
To con®rm the inhibitory eect of IkBb on NF-kB activation, we utilized an NF-kB reporter plasmid containing ®ve NF-kB binding sites upstream of the minimal thymidine kinase promoter and the reporter gene, secretory alkaline phosphatase (SEAP). The SEAP activity was measured quantitatively with a chemiluminescent SEAP Assay kit. First, the NF-kB-SEAP reporter gene was cotransfected with p65/RelA (NF-kB transactivation subunit) with increasing doses of the IkBb-HA plasmid into H441 cells and SEAP The pooled IkBb-expressing A549 cells (lower panel), like the individual clones, had signi®cantly reduced ability to form colonies as compared to untreated (7) vector control cells (upper panel) (10% FBS). When cultured in reduced serum (5 and 2.5% FBS), the untreated (7) vector control cells also exhibited reduced anchorage-independent growth. Addition (+) of IGF-I (20 nM) or EGF (200 nM) stimulated colony formation of vector control cells growth in both 5 and 2.5% FBS. In striking contrast, IGF-I failed to enhance colony formation of pooled IkBb-expressing cells at all serum conditions (10, 5 and 2.5% FBS). On the other hand, EGF could stimulate anchorage-independent growth of IkBbexpressing cells in both 5 and 2.5% FBS To further determine whether the activation of NFkB is impaired in A549 cells stably expressing the IkBb-HA protein, pooled cells of the latter or vector control cells were transfected with NF-kB-SEAP reporter plasmid and NF-kB activity was stimulated with TNFa. SEAP activity was strongly induced by TNFa (+) in vector control A549 cells as compared to unstimulated cells (7) (Figure 3b) . Interestingly, the basal activity of NF-kB in unstimulated vector control cells was much higher than that in IkBb-expressing cells. Hence, NF-kB is constitutively activated in unstimulated vector control cells leading to high basal NF-kB activity. Immunoblotting analysis demonstrated reduced levels of the p65/RelA protein detected in the nuclear fraction of IkBb-expressing cells as compared to vector control cells (data not shown), consistent with sequestration of NF-kB in the cytoplasm by IkBb. In addition to the low basal NF-kB activity in IkBbexpressing cells (7), addition of TNFa (+) failed to induce SEAP activity in these cells. Hence, stable expression of IkBb inhibited both basal and TNFastimulated NF-kB activity.
Since we have demonstrated that IGF-I and EGF can restore anchorage-independent growth of A549 vector control cells in reduced serum (Figure 2b , 5 and 2.5% FBS), we next examined if IGF-I or EGF can stimulate NF-kB activity in A549 cells. Indeed, IGF-I has been shown to activate NF-kB in hypothalamic GT1-7 cells (Heck et al., 1999) while EGF can activate NF-kB in A431 carcinoma cells and breast cancer cells (Sun and Carpenter, 1998; Biswas et al., 2000) . Vector control and IkBb-expressing cells were transfected with the NF-kB-SEAP reporter plasmid and stimulated with EGF or IGF-I. As shown in Figure 3c , both EGF and IGF-I induced NF-kB activity in vector control cells as compared to unstimulated cells (7) but failed to stimulate NF-kB activity in IkBb-expressing cells. As controls, TNFa strongly stimulated NF-kB activity in vector control cells but not in IkBbexpressing cells. 
Reduced growth of IkBb-expressing cells in low serum
Another phenotype of transformed cells is the ability to grow in reduced serum because of autocrine production of growth factors. The growth rates of vectortransfected A549 cells and IkBb-expressing cells in 10 and 0.5% FBS were compared. As shown in Figure 4a , expression of IkBb had no signi®cant eects on the growth rates of A549 cultured in 10% FBS. In striking contrast, while vector control cells grew similarly in 10 and 0.5% FBS, no increase in cell number was observed when IkBb-expressing cells were grown in 0.5% FBS (Figure 4a ). Therefore, expression of IkBb may disrupt the autocrine growth/survival signaling pathway in A549 cells.
To gain further insights into the latter,¯ow cytometry was performed on vector control cells and IkBb-expressing cells cultured in 10 or 0.5% FBS. Cell cycle analysis demonstrated no signi®cant dierences between vector and IkBb-expressing cells cultured in 0.5% FBS up to 7 days (data not shown), arguing against induction of cell cycle arrest as the mechanism underlying the lack of growth of IkBb-expressing cells in 0.5% FBS. However, the sub G 1 population was signi®cantly higher in IkBb-expressing cells cultured in 0.5% FBS after 5 days as compared to vector control, suggestive of the induction of apoptosis in the former. To investigate the latter, cells cultured in 10 or 0.5% FBS were assayed for apoptosis by TUNEL staining. As shown in Figure 4b , few TUNEL-positive cells were observed in vector control cells cultured in either 10 and 0.5% FBS. On the other hand, IkBb-expressing cells were more sensitive to apoptosis induced by low serum (0.5% FBS). The growth of IkBb-expressing cells in 0.5% FBS could be restored by conditioned medium from vector control cells, suggestive of the secretion of a growth/survival factor from the latter (data not shown).
Effects of IkBb expression on in vivo growth and lung metastasis
Because IkBb-expressing cells failed to proliferate in low serum in vitro, we next examined the eects of IkBb expression on growth in vivo. Vector control and IkBb-expressing A549 cells were injected subcutaneously into nude mice and the growth of tumors were monitored over time. After 1 month, animals were sacri®ced and the sizes of tumors were measured by calipers. As shown in Table 1 , expression of IkBb had no inhibitory eect on in vivo growth of A549 cells because tumors formed by vector control cells were not signi®cantly dierent from that formed by IkBbexpressing cells.
Since expression of IkBb had no inhibitory eect on subcutaneous tumor growth of A549 cells, we next examined if IkBb aected the metastatic growth of A549 cells after intravenous injection into the tail vein of nude mice. As shown in Figure 5a , all seven mice injected with vector control cells produced lung metastases, whereas only 2/7 mice injected with IkBbexpressing cells formed lung metastases (Figure 5b) . Hence, expression of IkBb only suppressed metastatic growth but not subcutaneous growth of A549 cells.
Discussion
NF-kB is an important transcription factor controlling the expression of numerous genes involved in the immune and in¯ammatory responses, apoptosis and cellular transformation. The biological activity of NFkB is controlled mainly by IkBa and IkBb, which restrict NF-kB to the cytoplasm and inhibit its DNA binding activity and transactivation function. The overall activation of NF-kB consists of two overlapping phases, a transient and persistent phase mediated through IkBa and IkBb, respectively (Thompson et al., 1995) . Depending on the cell type and stimulus, IkBs respond dierentially to various inducers of NF-kB. IkBa is a stronger inhibitor of nuclear NF-kB activity than IkBb or IkBe (Simeonidis et al., 1997; Tran et al., 1997) . In human endothelial cells, TNF caused sustained reduction in the levels of IkBb, resulting in persistent activation of NF-kB and induction of NF-kB-regulated genes (Johnson et al., 1996) . We have demonstrated that stable expression of IkBb inhibits TNFa-induced NF-kB activation in A549 cells ( Figure 3b) .
As reviewed by Mayo and Baldwin (2000) , NF-kB has been implicated in controlling cell growth and oncogenesis. NF-kB activity is required for rasmediated cellular transformation by suppressing p53-independent apoptosis induced by oncogenic ras (Finco et al., 1997; Mayo et al., 1997) . We have demonstrated that expression of wild-type IkBb inhibits anchorageindependent growth of K-ras transformed NIH3T3 cells and lung carcinoma cells harboring the K-ras oncogene (Figure 1) . We have also shown that IGF-I, a growth/survival factor, can enhance colony formation of vector control but not IkBb-expressing cells in reduced serum (2.5 and 5% FBS) (Figure 2b ). In contrast, EGF can enhance colony formation of both vector control and IkBb-expressing cells (Figure 2c) . Hence, NF-kB is required for anchorage-independent growth induced by IGF-I but not EGF and IGF-I signaling may be speci®cally inhibited in IkBb-expressing cells. This is consistent with the report demonstrating the requirement of JNK2 in EGF-induced colony formation of A549 cells (Bost et al., 1999) .
The loss of colony forming ability of IkBbexpressing cells (Figure 2a) is reminiscent of A549 cells expressing dominant-negative IGF-I receptor (Jiang et al., 1999) . The IGF-I receptor is the primary mediator of the action of IGF-I. Another similarity between A549 cells expressing dominant-negative IGF-I receptor or IkBb is enhanced sensitivity to apoptosis induced by proteasome inhibitors (data not shown). Inhibition of NF-kB has recently been shown to sensitize non-small cell lung cancer cells to chemotherapy-induced apoptosis (Jones et al., 2000) . Heck et al. (1999) also reported that IGF-I-mediated neuroprotec-tion against oxidative stress is associated with activation of NF-kB. Hence, it is tempting to speculate that the IGF-I signaling pathway regulating colony formation and apoptosis may be mediated by NF-kB. It will be interesting to examine if NF-kB activation is inhibited in A549 cells expressing dominant-negative IGF-I receptor and conversely, whether the IGF-Imediated growth and survival pathways are blocked in IkBb-expressing cells.
Although expression of IkBb in A549 cells has no eect on cell growth in 10% FBS, growth in 0.5% FBS was strongly inhibited (Figure 4a ). In contrast, the growth of vector control cells in 10 or 0.5% FBS was similar, probably due to the autocrine production of growth factors. In support for the latter, the growth of IkBb-expressing cells in 0.5% FBS could be restored by the addition of conditioned medium from vector control cells but not IkBb-expressing cells (data not shown). Serum-free medium conditioned by A549 cells has been shown to contain EGF which stimulates the growth of lung cancer cells (Siegfried, 1987) . However, addition of EGF or IGF-I fails to restore growth of IkBb-expressing cells in 0.5% FBS (data not shown), arguing against the role of these two factors. We hypothesize that the production of a factor required for cell growth and survival is mediated by the NF-kBsignaling pathway because increased apoptosis, but not cell cycle arrest, was observed in IkBb-expressing cells cultured in 0.5% FBS as compared to vector control (Figure 4b ). The identity of this putative NF-kBregulated growth/survival factor in the conditioned medium remains to be determined and is under investigation.
In addition to its role in cell growth and survival, NF-kB plays an important role in cellular transformation. Enhancement of NF-kB function by overexpression of IkBa antisense RNA induced malignant transformation as measured by growth in soft agar and tumorigenicity in nude mice (Beauparlant et al., 1994) . Expression of a dominant-negative IkBa mutant in squamous cell carcinoma also inhibits tumor growth in vivo (Duey et al., 1999) . Despite inhibition of colony formation of A549 cells, expression of IkBb had no inhibitory eect on tumor growth subcutaneously in nude mice (Table 1) . Although colony formation in vitro may correlate with tumorigenicity in vivo, there is also evidence demonstrating the lack of correlation between the two transformation assays (Dodson et al., 1981; Hastings and Franks, 1981) . One possible explanation is that the levels of expression of wildtype IkBb in A549 cells are sucient for inhibition of colony formation in vitro but not suppression of tumor growth in vivo. Since IkBa is a stronger inhibitor of NF-kB than IkBb, it is plausible that higher levels of expression of IkBb may be needed for suppression of tumorigenicity. In contrast, expression of dominantnegative IkBa in human melanoma cells has been shown to inhibit subcutaneous growth in nude mice (Huang et al., 2000) . Hence, it is plausible that wildtype IkBb and dominant-negative IkBa may have distinct eects on the various phenotypes of transformation, or alternatively, the eects of inhibition of NFkB on tumorigenicity may be cell-type speci®c. We have attempted without success to generate stable cell lines expressing wild-type IkBa, suggesting that overexpression of the latter may be toxic to A549 cells. This is consistent with the demonstration that expression of a`super-repressor' form of IkBa was cytotoxic to squamous lung cancer cells (Batra et al., 1999) . In contrast to the lack of eect of NF-kB inhibition on 
Materials and methods
Cells and antibodies
The human lung adenocarcinoma cell lines A549 and H441 were obtained from ATCC and cultured in Ham's F-12 and RPMI 1640 medium, respectively, supplemented with 10% fetal bovine serum (FBS) and incubated at 378C with 5% CO 2 . Rabbit anti-hemagglutinin (HA) antibody was purchased from Santa Cruz, Inc (Santa Cruz, CA, USA).
Transfection of IkBb-HA and alkaline phosphatase assays
IkBb tagged with an HA epitope at the carboxyl terminus was constructed by polymerase chain reaction and subcloned into the bicistronic vector pBEFneo (Jiang et al., 1999) to generate pBEF/IkBb-HA. The empty vector (pBEFneo) or pBEF/IkBb-HA was transfected into NIH3T3, A549 and H441 cells using Eectene (Qiagen). For stable expression of IkBb-HA, transfected cells were selected with G418 and G418-resistant colonies were analysed for the expression of IkBb-HA by immunoblotting with anti-HA antibody. To measure NFkB activity, cells were transfected with the NFkB-SEAP reported plasmid and alkaline phosphatase assays were detected using a commercial ELISA kit (Tropix, MA, USA).
Colony formation in soft agar
Anchorage-independent growth was assayed by the ability to grow in soft agar. The bottom agar was prepared in medium containing serum and 0.7% Bacto agar in a 6 cm tissue culture dish. 1.5610 5 cells were resuspended in medium containing serum and 0.4% agar and plated on top of the bottom agar. The cells were incubated at 378C for 4 weeks for growth of colonies. Colonies were visualized by staining with INT solution.
Cell growth, cell cycle analysis and apoptosis assays
Cell growth analysis was performed by quantitating the number of viable cells by Trypan blue exclusion using a hemacytometer. For cell cycle analysis, ethanol-®xed cells were treated with RNase A, stained with propidium iodide (100 mg/ml), and analysed by a Becton-Dickinson FACS analyzer. Cell cycle distribution was based on 2N and 4N DNA content. For apoptosis assays, trypsinized cells were spun onto cytospin slides which were ®xed in 4% formaldehyde at 48C for 25 min. Apoptotic cells were detected by TdT-mediated dUTP Nick-End Labelling (TUNEL) using the Promega kit (Madison, WI, USA).
Tumorigenicity and experimental lung metastasis assay
For tumorigenicity assay, 4610 6 vector control or IkBbexpressing A549 cells were injected subcutaneously into athymic nude mice. The growth of the tumors was monitored and measured at weekly intervals. Animals were sacri®ced 1 month after cell injection. Tumor volumes were calculated by the following formula: volume=0.46A6B 2 , where A is the larger and B is the smaller axis (Ovadia et al., 1975) . For experimental lung metastasis assay, vector control or IkBbexpressing A549 cells (2.5610 6 in a volume of 0.1 ml PBS) were injected into the lateral tail veins of nude mice. Animals were sacri®ced after 8 weeks and the lungs were ®xed in formalin and lung sections were stained with H&E.
Western blot
Western analysis was performed according to the procedure described previously (Jiang et al., 1999) . Brie¯y, the nitrocellulose membrane was blocked for 30 min at room temperature with 5% non-fat milk in 10 mM Tris-HCl, pH 7.5, 50 mM NaCl and 1% Tween 20 (TBS-T). The membrane was incubated with primary antibody in 0.5% non-fat dry milk in TBS-T at room temperature for 2 h. After incubation, the membrane was washed with TBS-T and incubated with secondary antibody conjugated with horseradish peroxidase for 1 h at room temperature. The membrane was washed again with TBS-T and analysed using an ECL kit (Amersham).
